Outperform Aurobindo Pharma., target Rs 910: Credit Suisse

Credit Suisse has Outperform call on Aurobindo Pharma Ltd. with a target price of Rs 910.0. The current market price of Aurobindo Pharma Ltd. is 839.35. Time period given by analyst is year, when Aurobindo Pharma Ltd. price can reach defined target. Aurobindo Pharma added $450 mn in market cap on Dolutegravir (DTG) approval. The global investment bank estimates peak profit contribution from DTG likely to be $10 mn. The global investment bank is of the view that the market has overestimated DTG potential for Aurobindo. The company has got a head start with approval but other 9 generics also pursuing the similar opportunity.